Clinical Research

Clinical Trials

Retrotope: Individual Patient Expanded Access Protocol for the Treatment of a Single Patient with Progressive Supranuclear Palsy with RT001

The Parkinson’s Institute is the only site worldwide with an FDA-approved compassionate use indication for RT001 in patients with Progressive Supranuclear Palsy (PSP). Learn more about RT001 here.

Status: Active, Not Enrolling

Learn more at retrotope.comIf you are interested, please call (650) 770-0205 or email

Questions about making a donation? Please call (650) 770-0201.

Email News and Updates

Join our mailing list to receive the latest news and updates from our team.

Parkinson's Institute and Clinical Center
2500 Hospital Drive, Building 10, Suite 1 | Mountain View, CA 94040
(650) 770-0201 main | (650) 770-0204 fax (secure clinic fax)

Federal Tax ID # 94-3061594